(Q33321951)

25 July 2017

title

Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years (English)

1 reference

25 July 2017

Karolina A Andersson

1

1 reference

25 July 2017

Max G Petzold

series ordinal

2

1 reference

25 July 2017

Peter Allebeck

series ordinal

3

1 reference

25 July 2017

Anders Carlsten

series ordinal

4

1 reference

25 July 2017

publication date

29 February 2008

1 reference

BMC Health Services Research

25 July 2017

published in

1 reference

25 July 2017

volume

8

1 reference

25 July 2017

page(s)

50

1 reference

Creative Commons Attribution 2.0 Generic

25 July 2017

copyright license

start time

29 February 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Does uncollected medication reduce the validity of pharmacy dispensing data?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276486

Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276486

European healthcare policies for controlling drug expenditure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276486

Adverse events associated with prescription drug cost-sharing among poor and elderly persons

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276486

How do practitioners evaluate the newly introduced system of substituting prescriptions?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276486

How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276486

The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276486

Fundholders' prescribing costs: the first five years

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276486

Multiuse of medicines in Finland.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276486

General practitioners' views on generic medication and substitution.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276486

Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-8-50

Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-8-50

Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-8-50

Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? Interrupted time series analysis of cost, volume and cost per volume trends in Sweden 1986-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-8-50

Prescription drug use, diagnoses, and healthcare utilization among the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-8-50

Use of analgesics in Sweden--the importance of sociodemographic factors, physical fitness, health and health-related factors, and working conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-8-50

A comparative analysis of generics markets in five European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-8-50

Decentralized responsibility for costs of outpatient prescription pharmaceuticals in Sweden. Assessment of models for decentralized financing of subsidies from a management perspective

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276486

Unclaimed prescriptions after automated prescription transmittals to pharmacies

31 October 2018

1 reference

12 December 2020

Physicians' attitudes toward generic drug substitution by pharmacists

1 reference

12 December 2020

What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden

1 reference

12 December 2020

Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study

1 reference

12 December 2020

The impact of decentralised drug-budgets in Sweden - a survey of physicians' attitudes towards costs and cost-effectiveness

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6963-8-50

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference